MAPKAPK2 and pancreatic neoplasm: On the other hand, we previously reported that p-HSP27, which is induced by gemcitabine via p38MAPK-MAPKAPK-2, plays a key role in the suppression of pancreatic cancer cell growth in stably transfected-mutant HSP27 pancreatic cancer cell lines [9].